Hair Cloning & Hair Multiplication research conducted by BERGMANN KORD & HAIR APLENTY Ltd through mesenchymal & stem cells from autologous hair follicles
A significant research on Hair Cloning & Hair Multiplication is conducted by BERGMANN KORD Hair Transplant Clinic, in cooperation with HAIR APLENTY Ltd. The research is based on the utilization of mesenchymal cells & stem cells from autologous hair follicles.
In search of a pioneer & innovative technology in hair transplants, BERGMANN KORD΄s and HAIR APLENTY΄s research holds since 2011 and aims at establishing a minimal invasive process of hair regeneration.
This patented technology has been developed by a specialized team of scientists (principally molecular biologists, dermatologists, and surgeons) and the research aims at ensuring a permanent solution for hair loss in men & women.
The research involves the following steps:
1. Extraction of autologous hair follicles
2. Multiplication of the stem cells in vitro under specific laboratory conditions
3. Infusion of the ad-hoc cells in the thinning or balding areas of the scalp
A basic benefit of this technique is that we extract only a small number of hair follicles and the multiplied cells are then infused in the thinning or balding area of the scalp, while the expected result could be the growth of new hair follicles.
The main advantages of this revolutionary on research application could be the following:
1. The permanence of the results (in comparison to the temporary results of the pharmaceutical hair loss treatments)
2. The surpassing of the limitations in hair transplants (in cases of poor donor supply).
Today, through hair tranplants we are only able to redistribute the existing hair and since we cannot create new hair, patients who have limited donor supply are not suitable candidates for hair transplants.
Hair Cloning & Hair Multiplication are fields of intensive research by scientists through the world. We are expecting the first results in a few months, while we have also arranged our participation to a wider clinical trial. The permanent character of the new treatment, along with the minimal invasive process and the fact that stem cells are a significant source of cells, all are parameters that can establish the new treatment as an exceptional alternative treatment for hair loss.